Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009127/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary purpose of participation in this study is to answer whether teriparatide is
superior to risedronate in reducing the occurrence of new vertebral fractures during 24
months of therapy.
提供机构：
Vivli
创建时间：
2023-07-31
